Skip to main content
Top

Breast Cancer

Issue 3/2022

Content (17 Articles)

Breast Cancer Review Article

Assessing the content based on ICF and quality based on COSMIN criteria of patient-reported outcome measures of functioning in breast cancer survivors: a systematic review

Farkhondeh Jamshidi, Maryam Farzad, Joy C. MacDermid, Azar Varahra, Seyed Ali Hosseini, Mojtaba Habibi Asgarabad

Breast Cancer Review Article

Does breast-conserving surgery with radiotherapy in BRCA-mutation carriers significantly increase ipsilateral breast tumor recurrence? A systematic review and meta-analysis

Miyako Nara, Sakiko Ishihara, Atsuko Kitano, Nobuko Tamura, Tomoyuki Aruga, Daiki Kobayashi, Seigo Nakamura, Hideko Yamauchi

Open Access Breast Cancer Review Article

Impact of exercise interventions on physical fitness in breast cancer patients and survivors: a systematic review

Salvatore Ficarra, Ewan Thomas, Antonino Bianco, Ambra Gentile, Petra Thaller, Fulvio Grassadonio, Sofia Papakonstantinou, Thorsten Schulz, Nils Olson, Alexandra Martin, Christian Wagner, Anna Nordström, Hande Hofmann

Breast Cancer Original Article

Sexuality in breast cancer survivors: sexual experiences, emotions, and cognitions in a group of women under hormonal therapy

F. M. Nimbi, S. Magno, L. Agostini, A. Di Micco, C. Maggiore, B. M. De Cesaris, R. Rossi, R. Galizia, C. Simonelli, R. Tambelli

Breast Cancer Original Article

Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy—results from the prospective multi-center BRENDA II study

Elena Leinert, Lukas Schwentner, Wolfgang Janni, Achim Wöckel, Saskia-L. Herbert, Daniel Herr, Thorsten Kühn, Felix Flock, Ricardo Felberbaum, Rolf Kreienberg, Visnja Fink, Davut Dayan, Kristina Ernst, Susanne Singer

Breast Cancer Original Article

Quality of life improvement in breast cancer survivors affected by upper limb lymphedema through a novel multiperspective physical activity methodology: a monocentric pilot study

Giuditta Carretti, Daniela Mirandola, Francesca Maestrini, Lisa Sequi, Sara Germano, Maria Grazia Muraca, Guido Miccinesi, Mirko Manetti, Mirca Marini

Breast Cancer Original Article

A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer

Anli Yang, Minqing Wu, Mengqian Ni, Lijuan Zhang, Mingyue Li, Peijun Wei, Yonggang Yang, Weikai Xiao, Xin An

Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow

Lisa Grüntkemeier, Aditi Khurana, Farideh Zamaniyan Bischoff, Oliver Hoffmann, Rainer Kimmig, Mathew Moore, Philip Cotter, Sabine Kasimir-Bauer

Breast Cancer Original Article

Is adjuvant chemotherapy necessary in older patients with breast cancer?

Midori Morita, Akihiko Shimomura, Emi Tokuda, Yoshiya Horimoto, Yukino Kawamura, Yumiko Ishizuka, Katsutoshi Sekine, Sayaka Obayashi, Yuki Kojima, Yukari Uemura, Toru Higuchi

Cancer Biomarker Original Article

BC-DETECT: combined detection of serum HE4 and TFF3 improves breast cancer diagnostic efficacy

Mohamed A. Abdelrazek, Ahmed Nageb, Lamiaa A. Barakat, Amr Abouzid, Rizk Elbaz

Metastasis Original Article

BAHD1 serves as a critical regulator of breast cancer cell proliferation and invasion

Ze-yu Yang, Su-peng Yin, Qingnan Ren, Deng-wei Lu, Tao Tang, Yao Li, Yi-zeng Sun, Hong-biao Mo, Ting-jie Yin, Zi-ying Yi, Jun-ping Zhu, Fan Zhang, Hongdan Chen

Open Access Mastectomy Original Article

Modification of oncoplastic breast surgery with immediate volume replacement using a thoracodorsal adipofascial flap

Munetsugu Hirata, Hiroko Toda, Naotomo Higo, Yoshiaki Shinden, Takao Ohtsuka, Yuko Kijima

Breast Cancer Original Article

CDC42 as an epigenetic regulator of ID4 in triple-negative breast tumors

Daniela Nasif, Sebastian Real, María Roqué, María T. Branham

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine